Trifluridine/tipiracil versus placebo in patients with heavily pretreated metastatic gastric cancer (TAGS): a randomised, double-blind, placebo-controlled, phase 3 trial
Published Online: 2018-11-?
Journal: The Lancet Oncology•Publisher: Elsevier BV
Authors: Aliaksandr Prokharau•Ayumu Hosokawa•Catia Faustino•David H Ilson•Edvard Zhavrid•Eric Van Cutsem•Giordano D Beretta•Hendrik-Tobias Arkenau•Josep Tabernero•Kazuhiro Nishikawa•Kazumasa Fujitani•Kohei Shitara•Lukas Makris•Maria Alsina•Michele Ghidini•Mikhail Dvorkin•Robert E Winkler•Toshihiko Doi•Vera Gorbunova•Wasat Mansoor•Şuayib Yalçın
